trial · primary record
Busulfan 3.2 mg/kg/day
Hematologic Malignancies
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 39 |
| Primary completion | 2027-09 |
| Primary endpoint | the number of grade 4 toxicities |
| Registry ID | NCT04098393 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:43.660Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04098393
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.